SampleFacts Closes $1.8M Funding Round Led by Nordic Science Investments, Stoaf III SciTech and Life Science Invest.

SampleFacts AB, a pioneering sample collection company, is pleased to announce the successful closure of a $ 1.8 million funding round. This latest round of investment was led by a team of Nordic Science Investments, Stoaf III SciTech and Life Science Invest with strong support from existing shareholders, including Landegren Gene Technology and Uppsala University Invest.

The funds raised will play a crucial role for advancing SampleFacts’ mission to transform sample collection with instant separation of blood cells and plasma, empowering healthcare and research with accuracy, efficiency and limitless applications. The capital infusion will be used to further develop the company’s cutting-edge technologies, enhance operational capabilities and accelerate commercialization and go-to-market strategy.

“We are very grateful for the trust and support of our investors. This funding round is not just a financial milestone, but also an expression of the belief in our vision, our team and the impact we are committed to making. This investment will enable us to push the boundaries and bring our groundbreaking solutions to market faster” said Maryam Poorafshar PhD, CEO of SampleFacts.

Effortless and Sustainable Sample Collection for Anyone, Anywhere, at Anytime

Nordic Science Investments, an early-stage investor specialized in science-driven companies, recognizes the transformative potential of SampleFacts’ technologies.

“As investors, we look for deep tech with the potential to shift entire workflows. SampleFacts does just that – bringing instant, on-the-spot separation of plasma and cells to remote sampling, and extending the range of feasible dried blood analyses. A game changer for biobanks.”

– Alexandra Gylfe PhD, Investment Manager at Nordic Science Investment.

Accuracy Efficiency and Limitless Applications

The funding round was also strongly supported by existing investors, including Uppsala University Invest (the investment arm of Uppsala University) and Landegren Gene Technology,

“Uppsala University Invest is proud to support Sample Facts in its mission. We are excited to be part of this committed investor consortium, enabling Sample Facts to take the next critical steps toward accelerating commercialization,” said Gunilla Lundmark, CEO.

“I am most gratified to see the strong interest by potential customers in SampleFacts’ technology. With this investment Maryam Poorafshar and her excellent team will have the resources to meet this interest and bring to market this much needed solution for extensive sample collection.” said Professor Ulf Landegren.

About SampleFacts AB

You can read more about SampleFacts AB and our journey here: About us